During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...

During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are ...

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

Oncologists utilizing artificial intelligence (AI) in their tests to spot pancreatic cancer at an early stage can also gain ...

Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic ...

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic ...

More on Root Causes of Cancer Cancer is a complex and multifaceted disease. While there are many known risk factors for specific types of cancer, the root causes of cancer, in general, can be ...

Are you aware of what your blood type is? With this piece of basic but important information, you may be able to determine ...

New trial data reveals atebimetinib combined with gemcitabine/nab-paclitaxel significantly improves survival rates in ...

As part of our strategic approach to improve outcomes for pancreatic cancer patients, our Scientific and Medical Affairs team conducts independent and collaborative research. We disseminate important ...

US-based ClearNote Health has started subject enrolment in a multi-centre, prospective study in the UK involving its Avantect pancreatic cancer test, to enhance early detection among individuals newly ...

A new blood test to pick up early signs of pancreatic cancer is being trialled by UK doctors. The genomic test uses blood samples to look for markers of the deadly disease, which often has vague ...